Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

Back to all news

NY Job Announcement - Deputy Director, BNE

Posted 9/9/2021

The New York Bureau of Narcotic Enforcement (BNE) is looking for a Deputy Director.  The position is responsible for the administration and oversight of the following programs: New York State's Prescription Drug Monitoring Program, Office Prescription Program, Electronic Prescribing, Prescriber Education, and Electronic Health Records Integration. Supervisory oversight for: BNE's program units, policy initiatives and activities, administration and public health initiatives, data collection and analysis, regulatory compliance, licensing and drug disposal, and Risk Assessment Program (internal controls). Additional responsibilities include, but are not limited to, the following: Oversight of development and implementation of new Bureau programs, regulatory changes, IT requests, grant activities, executive correspondence, and FOIL requests and responses. Oversight of the Bureau budget, including the development and submission of expenditure plans, oversight of purchasing, tracking of Bureau disbursements and timely payment of all invoices. Liaison with Department administrative and human resources staff relative to the hiring process, as well as the onboarding of new staff. Liaison with, including outreach and educational presentations to, the pharmacy and practitioner communities, professional organizations, and state and federal organizations.

The job posting is found here

Back to all news

Sponsor Spotlight

COMPASS Pathways


COMPASS Pathways is delighted to be a sponsor of NASCSA and looks forward to both engaging with controlled substances authorities, NASCSA leadership, and members to learn about their important work, and educate about our company's mission and the innovations underway using novel therapies.

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.

We are developing innovative therapies and, when appropriate, combining them with psychological support and next-generation digital tools to forge new, sustainable mental health care pathways.

Our investigational COMP360 psilocybin therapy is currently undergoing phase 3 investigation in treatment-resistant depression. We are also assessing COMP360 in anorexia nervosa and post-traumatic stress disorder, across multiple clinical studies.

Learn more https://www.compasspathways.com

All Sponsors